Obstet Gynecol Sci Search



  • HOME
  • Search
Gynecologic Oncology
Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
Tae-Wook Kong, Eun Ju Lee, Yonghee Lee, Suk-Joon Chang, Joo Hyuk Son, Hee-Sug Ryu
Obstet Gynecol Sci. 2014;57(6):539-543.   Published online November 20, 2014
Full text    PubReader    PDF    
Prognosis of stage IIB cervical cancer among treatment regimens: Radical hysterectomy vs. neoadjuvant chemotherapy followed by radical hysterectomy vs. concurrent chemoradiotherapy.
Young Ju Woo, Jung Mi Byun, Dae Hoon Jeong, Young Nam Kim, Su Seon Kim, Young Jin Seo, Moon Su Sung, Kyoung Bok Lee, Ki Tae Kim
Korean J Obstet Gynecol. 2012;55(12):913-919.   Published online December 18, 2012
Neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
Jung Bin Sohn, Duck Yeong Ro, Yong Wook Kim, Tae Eung Kim, Jae Keun Jung, Chi Wha Han, Ye Hoon Choi
Korean J Obstet Gynecol. 2007;50(10):1371-1377.   Published online October 1, 2007
Recent Management of FIGO stage IB2 Cervical Cancer.
Hyun Hoon Chung, Jae Weon Kim
Korean J Obstet Gynecol. 2005;48(9):2057-2066.   Published online September 1, 2005
Phase II Study of CP (Cisplatin/Paclitaxel) as Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Carcinoma.
Hei In Park, Jong Soo Kim, Seung Do Choi, Seob Jeon, Yoon Sook Kim, Dong Han Bae
Korean J Obstet Gynecol. 2005;48(3):659-668.   Published online March 1, 2005
Neoadjuvant Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer.
Sun Joo Lee, Jeong Won Lee, Chang Soo Park, Byoung Gie Kim, Je Ho Lee, Duk Soo Bae
Korean J Obstet Gynecol. 2004;47(4):627-633.   Published online April 1, 2004
Phase II trial of Neoadjuvant Paclitaxel and Cisplatin in Carcinoma of the Uterine Cervix.
Dong Choon Park, Jae Hoon Kim, Young Ok Lew, Dae Hoon Kim, Sung Eun Namkoong
Korean J Obstet Gynecol. 2002;45(4):682-686.   Published online April 1, 2002
The outcome of the cervical cancer (stage Ib1) treated by radical surgery with and without neoadjuvant chemotherapy.
Chul Hoi Jeong, Jeong Soo Kim, Eun Jeoung Kang, Kyoung Bok Lee, Ki Tae Kim, Hyun Chan Kim
Korean J Obstet Gynecol. 1999;42(11):2570-2575.   Published online January 1, 2001
The Study for Usefulness of Overexpression of bcl-2 , p53 Gene and Apoptosis as a Response Predictor to Neoadjuvant Chemotherapy in Cervical Cancer.
C M Lee, H I Cho, J S Kang
Korean J Obstet Gynecol. 1999;42(5):1096-1101.   Published online January 1, 2001
A Case of Primary Cancer of Vagina.
D I Kim, H W Choi, S J Lim, Y K Park, C Y Huh, S B Kim
Korean J Obstet Gynecol. 1998;41(11):2879-2882.   Published online January 1, 2001
Tumor Angiogenesis in Uterine Cervical Neoplasia and Relation of Angiogenesis to Neoadjuvant Chemotherapy.
I C Lee, J Y Won, S S Kim, D H Kim, T H Lee, S S Jeon, J S Kwak, Y L Cho
Korean J Obstet Gynecol. 1998;41(7):1805-1810.   Published online January 1, 2001
Clinical Profiles of Telemerase Activety in Uterine Cervical Carcinoma.
Sam Hyun Cho, Joong Bae Yoo, Seung Ryong Kim, Kee Sung Kim, Myung Jae Ra, Kyung Tai Kim, Hyung Moon, Youn Yeung Hwang
Korean J Obstet Gynecol. 1997;40(4):830-837.   Published online January 1, 2001
The Effect of Neoadjuvant Chemotherapy in Uterine Cervical Cancer.
Hyo Pyo Lee, Noh Hyun Park, Jae Weon Kim, Chang Won Koh, Yong Sang Song, Soon Beom Kang
Korean J Obstet Gynecol. 1997;40(2):379-386.   Published online January 1, 2001
  • Journal Impact Factor 1.9
  • SCImago Journal & Country Rank
  • 2.9
    57th percentile
    Powered by  Scopus
  • Cervical conization with endoCUT mode applying gastrointestinal endoscopic polypectomy technique. Obstet Gynecol Sci. 2023;66:584-586

Article category

Browse all articles >


Browse all articles >

Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2266-7238    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2024 by Korean Society of Obstetrics and Gynecology.

Developed in M2PI

Close layer
prev next